Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadine Gervois

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|January 30, 2023
Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapyAnne Jarry, Nadine Gervois, Celine Bossard, et al.
Medecine Sciences : M/S|July 3, 2003
[Adoptive immunotherapy in solid tumors: new hope]Francine Jotereau, Nathalie Labarrière, Nadine Gervois, et al.
Bulletin Du Cancer|September 6, 2003
[Passive immunotherapy of melanoma]Francine Jotereau, Nathalie Labarriere, Nadine Gervois, et al.
Cancer Immunology, Immunotherapy : CII|July 25, 2007
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sortingNathalie Labarrière, Nadine Gervois, Annabelle Bonnin, et al.
Bulletin Du Cancer|September 25, 2018
[Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment]Tilda Passat, Yann Touchefeu, Nadine Gervois, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapyLaurent Derre, Murielle Corvaisier, Marie-Christine Pandolfino, et al.
Journal of Medicinal Chemistry|March 3, 2007
Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cellsCéline Douat-Casassus, Nathalie Marchand-Geneste, Elisabeth Diez, et al.
International Journal of Cancer|April 10, 2009
Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusionsJuliette Desfrançois, Laurent Derré, Murielle Corvaisier, et al.
Journal of Medicinal Chemistry|September 3, 2010
Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognitionCéline Douat-Casassus, Oleg Borbulevych, Marion Tarbe, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2002
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patientsNathalie Labarrière, Marie-Christine Pandolfino, Nadine Gervois, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|January 30, 2023
Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapyAnne Jarry, Nadine Gervois, Celine Bossard, et al.
Medecine Sciences : M/S|July 3, 2003
[Adoptive immunotherapy in solid tumors: new hope]Francine Jotereau, Nathalie Labarrière, Nadine Gervois, et al.
Bulletin Du Cancer|September 6, 2003
[Passive immunotherapy of melanoma]Francine Jotereau, Nathalie Labarriere, Nadine Gervois, et al.
Cancer Immunology, Immunotherapy : CII|July 25, 2007
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sortingNathalie Labarrière, Nadine Gervois, Annabelle Bonnin, et al.
Bulletin Du Cancer|September 25, 2018
[Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment]Tilda Passat, Yann Touchefeu, Nadine Gervois, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapyLaurent Derre, Murielle Corvaisier, Marie-Christine Pandolfino, et al.
Journal of Medicinal Chemistry|March 3, 2007
Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cellsCéline Douat-Casassus, Nathalie Marchand-Geneste, Elisabeth Diez, et al.
International Journal of Cancer|April 10, 2009
Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusionsJuliette Desfrançois, Laurent Derré, Murielle Corvaisier, et al.
Journal of Medicinal Chemistry|September 3, 2010
Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognitionCéline Douat-Casassus, Oleg Borbulevych, Marion Tarbe, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2002
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patientsNathalie Labarrière, Marie-Christine Pandolfino, Nadine Gervois, et al.
Pageof 4